Organogenesis Announces Publication of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit of Affinity™ in the Most Challenging and Complex Venous Leg Ulcers
Go back to Organogenesis Announces Publication of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit of Affinity™ in the Most Challenging and Complex Venous Leg Ulcers| (NASDAQ: ORGO) | Delayed: 1.71 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.71 | 52 Week High | $ | |||
| Open | $1.71 | 52 Week Low | $ | |||
| Day High | $1.71 | P/E | N/A | |||
| Day Low | $1.71 | EPS | $ | |||
| Volume | 15 | |||||
